SARS-CoV-2 感染症は,プロフィブロティックなマクロファージ反応と肺線維症を引き起こす
Daniel Wendisch1, Oliver Dietrich2, Tommaso Mari3
1Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Cell
|December 16, 2021
まとめ
重度のCOVID-19は,プロフィブロティックマクロファージを誘発し,肺線維症を引き起こすことで,急性呼吸器障害症候群 (ARDS) を引き起こします. この研究は,SARS-CoV-2がマクロファージにおけるこれらの線維反応を直接誘発することを明らかにしています.
科学分野:
- 免疫学
- 肺医学
- 病理学について
背景:
- COVID-19に起因する急性呼吸器障害症候群 (ARDS) は,呼吸器不全と高い死亡率につながる.
- COVID-19 ARDSの肺損傷を誘発する正確なメカニズムは,まだ完全に理解されていません.
研究 の 目的:
- COVID-19 ARDS患者の肺免疫反応と肺病理を分析する.
- COVID-19 ARDSの肺線維症の発症におけるマクロファージの役割を調査する.
主な方法:
- 機能的な単細胞ゲノミクス
- 免疫ヒストロジー
- 電子顕微鏡
- ヒト単細胞のSARS-CoV-2へのインビトロ暴露
主要な成果:
- COVID-19 ARDS肺におけるプロフィブロティックな転写フェノタイプを持つCD163発現する単細胞由来マクロファージの蓄積.
- COVID-19に関連したマクロファージとプロフィブロティックマクロファージの特徴的な類似性.
- COVID-19 ARDSは,肺線維症の臨床的,放射線的,組織病理学的,超構造的特徴を示しています.
- 実験室内では,SARS-CoV-2への曝露により,ヒト単細胞におけるプロフィブロティック現象型が誘発された.
結論:
- SARS-CoV-2 感染症はプロフィブロティックなマクロファージの反応を誘発する.
- これらの反応は,COVID-19における顕著な線維増殖性急性呼吸器障害症候群に寄与する.
- この発見は,SARS-CoV-2とARDSにおける肺線維症の発症の間の直接的な関連性を強調しています.
関連する概念動画
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.3K
Pulmonary Tuberculosis II
611
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
611
Pneumonia II: Pathophysiology
919
The pathophysiology of pneumonia involves the following steps:
919
Cystic Fibrosis: Pathogenesis
393
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
393
COPD: Pathogenesis and Clinical Features
678
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
678


